Clinical Study of Yiqi Tongluo Prescription on Interventional Restenosis of Ischemic Cerebrovascular Disease
- Conditions
- Ischemic Cerebrovascular Disease
- Registration Number
- ITMCTR2000003899
- Lead Sponsor
- Dongfang Hospital of Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients with ischemic cerebrovascular disease were diagnosed by imaging examination;
2. Patients aged 35-80 years old;
3. Patients with endovascular interventional therapy;
4. Patients with Qi deficiency, blood stasis and phlegm obstruction were diagnosed by TCM syndrome score scale;
5. Patients with 0-2 scores of modified Rankin scale before onset of disease;
6. Patients who voluntarily participated in the study and have signed informed consent.
1. Patients who are expected to survive for less than 2 years;
2. Patients with severe systemic diseases or unsuitable / intolerant dual antiplatelet therapy;
3. Patients with severe neurological dysfunction (MRS score >= 3) before the stroke or TIA attack;
4. Patients with severe myocardial infarction within 2 weeks;
5. Patients with moyamoya disease, active arteritis and unexplained non atherosclerotic stenosis;
6. Patients with international normalized ratio (INR) > 1.5;
7. Pregnant women;
8. Patients who are not suitable for endovascular therapy as judged by neurologists and Neurointerventional physicians.
9. Patients with severe heart, liver and kidney damage;
10. Patients with a history of mental illness and mental retardation.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Degree of arterial stenosis;
- Secondary Outcome Measures
Name Time Method FABP4;Adverse events;NIHSS, mRS, BI;